Yi Zhao

17 articles listing Yi Zhao in Nature Communications, Science Advances, PNAS, Science, indexed by Paperzzz from Crossref and OSF.

  1. Gut microbiota-activated PLCγ2 monocytes drive atrial fibrillation Nature Communications
  2. Near-infrared-active Nd–BiO2-x/MIL-101(Fe) with vacancy-induced interfaces for solar water purification Nature Communications
  3. Westerly induced precipitation increase drives near-surface ground ice gain on the Tibetan Plateau despite warming Science Advances
  4. A high-dexterity soft neuroprosthetic hand for daily activities Nature Communications
  5. Spatially coupled CO2 activation and hydrogenation sites in 1 T′-MoS2 enable near-unity methanol selectivity Nature Communications
  6. HOP2–MND1 chaperones a diffusing DMC1–ssDNA complex to survey dsDNA for homology recognition during meiotic recombination PNAS
  7. Bioinspired flexible sensing-processing-visualizing integrated system towards tactile-visual signal recognition Nature Communications
  8. Chinese Immune Multi-Omics Atlas Science
  9. Deep learning-assisted discovery of a potent and cell-active inhibitor of RNA N6-methyladenosine recognition protein YTHDC2 Nature Communications
  10. Self-growth of programmable 2D- and 3D-coupling responsive coating for anti-counterfeiting Nature Communications
  11. Human alterations to global riverine phosphorus fluxes to the ocean Science Advances
  12. A rapid self-healing polymer mediated by ion aggregates achieves effective encapsulation of sustainable perovskite solar cells Science Advances
  13. LINS: A general medical Q&A framework for enhancing the quality and credibility of LLM-generated responses Nature Communications
  14. A magneto-responsive nanomesh biosensor for simultaneous mechanical stimulation and electrochemical detection Nature Communications
  15. Single-nuclei multiomics analysis identifies abnormal cardiomyocytes in a murine model of cardiac development Nature Communications
  16. A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis Nature Communications
  17. Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial Nature Communications